Order results by:
| Issue | Title | |
| Vol 8, No 4 (2016) | GLOBAL CLINICAL PRACTICE AND PERSONALIZED CHOICES FOR ORAL ANTICOAGULANT THERAPY FOR NON-VALVULAR ATRIAL FIBRILLATION | Abstract similar documents |
| A. V. Fonyakin, L. A. Geraskina | ||
| "... oral anticoagulants (DOACs). The start of clinical use of these agents has opened a new page in oral ..." | ||
| Vol 6, No 4 (2014) | Current guidelines and prospects for using novel oral anticoagulants for nonvalvular atrial fibrillation | Abstract similar documents |
| A. V. Fonyakin | ||
| "... into account when choosing oral anticoagulant therapy after hemorrhagic stroke in patients at high risk ..." | ||
| Vol 16, No 4 (2024) | Ten rules for oral anticoagulants prescription after a stroke | Abstract PDF (Eng) similar documents |
| A. A. Kulesh, D. A. Demin, S. S. Kucherenko | ||
| "... Every third or fourth ischemic stroke is cardioembolic. Prescribing oral anticoagulants can ..." | ||
| Vol 4, No 3 (2012) | A new era of anticoagulant therapy in the prevention of stroke in non-rheumatic atrial fibrillation | Abstract similar documents |
| Andrei Viktorovich Fonyakin, L A Geraskina | ||
| "... arrhythmia and a common cause of cardiogenic cerebral embolism. Oral anticoagulant therapy is a leader ..." | ||
| Vol 7, No 2 (2015) | The fifth anniversary of clinical use of new oral anticoagulants in non-valvular atrial fibrillation | Abstract similar documents |
| A. V. Fonyakin | ||
| "... a new page in oral anticoagulant therapy aimed at preventing thromboembolic events in AF. Dabigatran ..." | ||
| Vol 6, No 2S (2014): Special issue "Stroke" | Secondary prevention of stroke in atrial fibrillation, use of apixaban: ARISTOTLE, AVERROES studies | Abstract similar documents |
| V.A. Parfenov, S.V. Verbitskaya | ||
| "... and new oral anticoagulants: inhibitors of Xa factor (apixaban, rivaroxaban) and direct thrombin inhibiror ..." | ||
| Vol 8, No 1 (2016) | Hemorrhagic stroke and oral anticoagulants: What is to be done? | Abstract similar documents |
| M. A. Domashenko | ||
| "... in the incidence of intracranial hemorrhage (ICH) associated with the use of oral anticoagulants. The paper ..." | ||
| Vol 14, No 3 (2022) | Anticoagulant therapy as a part of secondary stroke prevention in patients with atrial fibrillation | Abstract similar documents |
| O. D. Ostroumova, T. M. Ostroumova | ||
| "... with patients with sinus rhythm. The main method of preventing recurrent IS in AF is the administration of oral ..." | ||
| Vol 12, No 4 (2020) | Atrial fibrillation and cognitive impairment: cerebral microbleeds as a new risk factor and possibilities of anticoagulant therapy (Part 2) | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, T. M. Ostroumova | ||
| "... to the role of oral anticoagulants (OACs) in the prevention of CI in AF, which is reflected in a number ..." | ||
| Vol 13, No 5 (2021) | Difficult issues in the management of patients with atrial fibrillation: a neurologist's point of view | Abstract PDF (Eng) similar documents |
| A. A. Kulesh | ||
| "... The article evaluates recent perspectives about the role of oral anticoagulants in the secondary ..." | ||
| Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания | Atherothrombotic stroke in non-valvular atrial fibrillation | Abstract similar documents |
| I. S. Yavelov, E. Yu. Okshina | ||
| "... in preventing non-cardioembolic (atherothrombotic in particular) strokes, and the widespread use of oral ..." | ||
| Vol 7, No 1 (2015) | Cardioembolic stroke | Abstract similar documents |
| I. V. Damulin, D. A. Andreev, Z. K. Salpagarova | ||
| "... to ischemic stroke. Oral anticoagulants, the efficacy and safety of which have been proven in large clinical ..." | ||
| Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания | Intracranial hemorrhage in patients taking oral anticoagulants. Current possibilities for therapy | Abstract similar documents |
| S. N. Yanishevsky | ||
| "... oral anticoagulants. The incidence of ICH is shown to be considerably lower when nonvitamin K-dependent ..." | ||
| Vol 13, No 5 (2021) | Anticoagulant therapy for stroke prevention in patients with severe COVID-19 | Abstract similar documents |
| A. T. Azimov, G. S. Rakhimbaeva, F. Z. Azimov | ||
| "... with severe disease course. Objective: to determine the safest and most effective anticoagulant for stroke ..." | ||
| Vol 12, No 3 (2020) | Oral anticoagulant therapy in patients after intracerebral hemorrhage | Abstract PDF (Eng) similar documents |
| A. A. Kulesh, L. I. Syromyatnikova | ||
| "... The presence of indications for long-term oral anticoagulant (OAC) therapy in a patient who has ..." | ||
| Vol 12, No 3 (2020) | Atrial fibrillation and cognitive impairment: prevalence and pathophysiological mechanisms for the relationship (Part 1) | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, T. M. Ostroumova | ||
| Vol 10, No 3 (2018) | Current strategies to improve the efficiency and safety of prevention and treatment of embolic stroke in non-valvular atrial fibrillation: possibilities of neutralizing therapy | Abstract similar documents |
| S. N. Yanishevsky | ||
| "... with ischemic stroke (IS) who take oral anticoagulants. The possibilities of providing effective and relatively ..." | ||
| Vol 10, No 2 (2018) | Molecular mechanisms of action of glucosamine sulfate in the treatment of degenerative-dystrophic diseases of the joints and spine: results of proteomic analysis | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, A. M. Lila, A. N. Gromov | ||
| Vol 9, No 2 (2017) | Antiplatelet therapy strategies for ischemic stroke | Abstract similar documents |
| M. Yu. Maksimova, A. V. Fonyakin, L. A. Geraskina | ||
| "... . Parenteral anticoagulants in acute stroke decrease the risk of venous thrombosis/thromboembolism, oral ..." | ||
| Vol 13, No 6 (2021) | Cardioembolic stroke: classification of causes and prevention strategies | Abstract similar documents |
| A. V. Fonyakin, L. A. Geraskina | ||
| "... for the prevention of stroke in this pathology is oral anticoagulant therapy with direct oral anticoagulants ..." | ||
| Vol 8, No 4 (2016) | IMPACT OF ANTICOAGULANT THERAPY ON THE INDICATORS OF ARTERIAL STIFFNESS AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ATRIAL FIBRILLATION AFTER CARDIOEMBOLIC STROKE | Abstract similar documents |
| I. A. Zolotovskaya, I. L. Davydkin, I. E. Poverennova, N. P. Romanchuk | ||
| "... Objective: to investigate the impact of anticoagulant therapy on the indicators of arterial ..." | ||
| Vol 14, No 6 (2022) | Issues of improving the management of patients with ischemic stroke on the background of atrial fibrillation | Abstract similar documents |
| A. A. Kulesh, D. A. Demin | ||
| "... of atrial cardiopathy and its main markers. The principles for choosing the timing of oral anticoagulant ..." | ||
| Vol 11, No 2 (2019) | Possible timing for anticoagulation therapy initiation in ischemic stroke patients with atrial fibrillation: further analysis of the hemorrhagic transformation index | Abstract PDF (Eng) similar documents |
| M. N. Kalinin, D. R. Khasanova, M. M. Ibatullin | ||
| "... an appropriate scale (the hemorrhagic transformation index (HTI)) to clarify the possible timing of anticoagulant ..." | ||
| Vol 13, No 4 (2021) | Oral administration of cyanocobalamin for functional vitamin В12 deficiency: efficacy and safety | Abstract similar documents |
| E. V. Shikh, Zh. M. Sizova, M. O. Astaeva | ||
| "... expectations for the oral administration of cyanocobalamin in therapeutic doses. Comparative clinical trials ..." | ||
| Vol 12, No 2 (2020) | Current approaches to diagnosing in intracerebral hemorrhage | Abstract PDF (Eng) similar documents |
| A. A. Kulesh | ||
| "... microangiopathy, the use of oral anticoagulants (OACs) and their combination, and arteriovenous malformations ..." | ||
| Vol 7, No 4 (2015) | Topical issues of the efficiency and safety of using the first direct thrombin inhibitor in real clinical practice | Abstract similar documents |
| A. V. Fonyakin | ||
| "... . It was particularly emphasized that direct oral anticoagulants along with warfarin as fist-line agents might be used ..." | ||
| Vol 6, No 3 (2014) | The risk factors and prevention of stroke in atrial fibrillation | Abstract similar documents |
| V. A. Parfenov, S. V. Verbitskaya | ||
| "... randomized trials that show that novel oral anticoagulants (dabigatran, rivaroxaban, apixaban) are as good ..." | ||
| Vol 14, No 6 (2022) | Cognitive impairment and small vessel disease in atrial fibrillation | Abstract similar documents |
| P. M. Krupenin, O. N. Voskresenskaya, D. A. Napalkov, A. A. Sokolova | ||
| "... oral anticoagulants (DOACs). Patients underwent cognitive testing, screening ultrasound examination ..." | ||
| Vol 5, No 4 (2013) | Venous thromboses and thromboembolism in acute stroke: risk factors, diagnosis, treatment, and prevention | Abstract similar documents |
| Andrei Viktorovich Fonyakin, L A Geraskina | ||
| "... the risk of hemorrhagic complications. Novel oral anticoagulants used to treat venous thrombosis and VTE ..." | ||
| Vol 15, No 3 (2023) | Vitamin B12 deficiency and Parkinson’s disease | Abstract similar documents |
| Z. A. Zalyalova, E. V. Ekusheva | ||
| "... changes. Modern data on the use of high-dose (1000 μ g) oral vitamin B12 are presented, it has comparable ..." | ||
| Vol 6, No 2 (2014) | Dabigatran etexilate for nonvalvular atrial fibrillation in real practice and promises for its use to prevent stroke | Abstract similar documents |
| A.V. Fonyakin | ||
| "... fibrillation (AF) are substantially extended after designing and clinically introducing new oral anticoagulants ..." | ||
| Vol 14, No 6 (2022) | Drug-induced non-traumatic intracranial hemorrhage associated with the use of anticoagulants and antiplatelet agents | Abstract similar documents |
| O. D. Ostroumova, A. I. Listratov, T. M. Ostroumova, A. I. Kochetkov, D. A. Sychev | ||
| "... are antithrombotic drugs: anticoagulant, antiplatelet and thrombolytic. The main risk factors for ICH are advanced ..." | ||
| Vol 6, No 1 (2014) | Rivaroxaban in secondary prevention of cardioembolic stroke: standards and abnormal situations | Abstract similar documents |
| A.V. Fonyakin, L.A. Geraskina | ||
| "... with nonvalvular atrial fibrillation (AF) were significantly broadened after new oral anticoagulants (NOC) have ..." | ||
| Vol 11, No 4 (2019) | Acute coronary syndrome in a patient with transient ischemic attack: challenges of antithrombotic therapy (a clinical case) | Abstract similar documents |
| E. Yu. Kovalchuk, A. S. Povzun, V. A. Kostenko, A. V. Brega | ||
| "... , based on existing recommendations, the optimal anticoagulant is chosen as part of triple and double ..." | ||
| Vol 5, No 4 (2013) | Cardioembolic stroke: a variety of causes and current approaches to its prevention | Abstract similar documents |
| Lyudmila Aleksandrovna Geraskina | ||
| Vol 5, No 3 (2013) | Prevention of venous thromboembolic events in ischemic stroke | Abstract similar documents |
| Vladimir Anatolyevich Parfenov | ||
| "... The prevention of venous thromboembolic events (VTEEs) combining leg vein thrombosis and pulmonary ..." | ||
| Vol 8, No 4 (2016) | USE OF DIMETHYL FUMARATE IN THE TREATMENT OF MULTIPLE SCLEROSIS: CLINICAL AND ECONOMIC ANALYSIS | Abstract similar documents |
| V. R. Mkrtchyan, L. V. Brylev, I. A. Shpak, A. M. Sergeev | ||
| "... evaluation was made to study the use of first-line oral dimethyl fumarate versus another first-line oral ..." | ||
| Vol 4, No 1S (2012): Special issue "Epilepsy" | Efficacy and tolerance of intravenous lacosamide in urgent neurological situations | Abstract similar documents |
| P. N. Vlasov, E. G. Kamelkova, F. R. Drozzhina | ||
| "... is promising when its oral use is impossible, including in therapy for status epilepticus/series of partial ..." | ||
| Vol 16, No 1S (2024): Спецвыпуск: Головная боль | Gastric stasis in migraine and the efficacy of antimigraine drugs | Abstract similar documents |
| G. R. Tabeeva, A. A. Kharitonova | ||
| "... . Among the most common are nausea and vomiting, which limit the intake of oral medications and thus ..." | ||
| Vol 5, No 2S (2013): Special issue "Stroke" | Current approaches to antithrombotic therapy in patients with cardioembolic stroke | Abstract similar documents |
| Oleg Ivanovich Vinogradov, A N Kuznetsov, N V Rybalko | ||
| "... of trials of new oral anticoagulants, and latest guidelines for antithrombotic therapy to prevent stroke ..." | ||
| Vol 4, No 4 (2012) | Subtypes of ischemic cerebral circulation disorders at young age: diagnosis and treatment | Abstract similar documents |
| Natalia Vyacheslavovna Pizova | ||
| "... tissue plasminogen activator is more frequently used; oral anticoagulants and antiplatelet agents ..." | ||
| Vol 1, No 2 (2009) | ANTITHROMBOTIC THERAPY IN THE PREVENTION OF RECURRENT ISCHEMIC STROKE | Abstract similar documents |
| A. V. Fonyakin | ||
| "... therapy with oral anticoagulants is reasonable in cardioembolic stroke caused by atrial fibrillation ..." | ||
| Vol 15, No 2 (2023) | Clinical course and diagnosis of cerebral vein and sinus thrombosis associated with COVID-19 in young and middle-aged patients | Abstract similar documents |
| E. G. Klocheva, V. V. Goldobin, F. Z. Olimova | ||
| "... to recognize, it is potentially a life threatening condition and requires timely anticoagulant therapy ..." | ||
| Vol 15, No 1 (2023) | Chondroprotectors as modulators of neuroinflammation | Abstract similar documents |
| I. Y. Torshin, O. A. Gromova, A. G. Nazarenko | ||
| "... receptor, leading to inhibition of the pro-inflammatory factor NFκB, antiatherosclerotic and anticoagulant ..." | ||
| Vol 5, No 2 (2013) | Dabigatran experience in primary and secondary prevention of cardioembolic stroke | Abstract similar documents |
| Maksim Alekseyevich Domashenko, M Yu Maksimova, D Z Korobkova, M E Gafarova | ||
| "... The review of novel oral anticoagulants (dabigatran, rivaroxaban and apixaban) in stroke prevention ..." | ||
| Vol 3, No 4 (2011) | Pharmacoeconomic analysis of the use of movalis (meloxicam) in patients with nonspecific back pain | Abstract similar documents |
| O. N. Gerasimova, V. A. Parfenov | ||
| "... in the outpatient setting. Movalis was given in a single daily oral dose of 15 mg throughout the follow-up; the oral ..." | ||
| Vol 13, No 2 (2021) | Chemoreactom analysis of cytidyldiphosphocholine indicates synergistic combinations of neuroprotective agents | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, L. A. Mayorova, T. R. Grishina, L. E. Fedotova, A. N. Gromov, I. S. Sardaryan | ||
| "... . The cholinergic effect of CDP-choline is enhanced by the anti-inflammatory, anticoagulant, and neuroprotective ..." | ||
| Vol 12, No 1 (2020) | The first experience with thrombolytic therapy for cerebral infarction in the Russian Federation after the use of idarucizumab | Abstract similar documents |
| E. V. Pudov, N. N. Sukhacheva, I. S. Petelina | ||
| "... to neutralize the anticoagulant effect of dabigatran. At 24 hours after TLT, the National Institutes of Health ..." | ||
| Vol 1, No 3-4 (2009) | ANTITHROMBOCYTIC THERAPY IN THE SECONDARY PREVENTION OF ISCHEMIC STROKE | Abstract similar documents |
| A. V. Fonyakin, L. A. Geraskina | ||
| "... not limit the choice of an antithrombocytic agent to only oral (indirect) anticoagulants (OAC). If OAC ..." | ||
| Vol 15, No 2 (2023) | Efficacy and safety of aceclofenac in musculoskeletal diseases | Abstract similar documents |
| M. A. Isaikina, A. I. Isaikin, L. T. Akhmedzhanova | ||
| "... arthritis and other diseases recommend oral non-steroidal anti-inflammatory drugs as first-line therapy ..." | ||
| Vol 7, No 4 (2015) | Dysphagia after stroke | Abstract similar documents |
| D. O. Gromova, V. V. Zakharov | ||
| "... for these patients. The authors show the advantages of fast-dissolving oral medicines used in the therapy of patients ..." | ||
| Vol 10, No 1 (2018) | Cranial dystonia | Abstract similar documents |
| V. A. Tolmacheva | ||
| "... cranial dystonia. If their administration cannot achieve a positive result, oral drugs and surgical ..." | ||
| Vol 1, No 3-4 (2009) | CITICOLIN IN THE TREATMENT OF STROKE AND VASCULAR COGNITIVE DISORDERS | Abstract similar documents |
| V. A. Parfenov | ||
| "... evidence for the efficacy of intravenous or oral citicolin used within the first 24 hours of ischemic ..." | ||
| Vol 3, No 3 (2011) | Treatment for poststroke spasticity, the use of mydocalm | Abstract similar documents |
| V. A. Parfenov | ||
| "... as oral medications. The paper also presents the results of a placebo-controlled trial that has indicated ..." | ||
| Vol 4, No 1 (2012) | New possibilities in the prevention of stroke in atrial fibrillation | Abstract similar documents |
| Vladimir Anatolyevich Parfenov, S V Verbitskaya | ||
| "... into neurological care may increase the number of patients receiving effective anticoagulant therapy to prevent re ..." | ||
| Vol 3, No 1 (2011) | Current aspects of the epidemiology and treatment of chronic brain ischemiain the presence of essential hypertension (results of the CALIPSO program) | Abstract similar documents |
| E. I. Chukanova | ||
| "... and 50 mg on days 5 to 7) then oral Cavinton forte, 30 mg/day, for 90 days. Therapy with Cavinton ..." | ||
| Vol 8, No 3 (2016) | Chemoreactome analysis of ethylmethylhydroxypyridine succinate | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, L. E. Fedotova, A. N. Gromov | ||
| "... , and anticoagulant actions, activates homocysteine neutralization and anti-inflammatory protection, and decreases ..." | ||
| Vol 9, No 2 (2017) | Chemoreactomic analysis of citrulline malate molecules | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, L. E. Fedotova, A. N. Gromov, K. V. Rudakov | ||
| "... malate can also show anticoagulant, antivasopressor, hypoglycemic, antihypercholesterolemic ..." | ||
| Vol 7, No 4 (2015) | Some aspects of treatment for cognitive impairments. Cyticolin: pharmacological characteristics, possible benefits, aspects of use | Abstract similar documents |
| N. V. Trofimova, I. S. Preobrazhenskaya | ||
| "... pathways of acetylcholine biosynthesis. The VITA and IDEALE have shown that the parenteral and oral ..." | ||
| Vol 7, No 4 (2015) | Possibilities of using naftidrofuryl in the therapy of cerebrovascular diseases: Literature review and the authors’ observations | Abstract similar documents |
| A. N. Belova, D. N. Shakurova, E. V. Gayazova | ||
| "... in this category of patients. The data available in the literature suggest that oral naftidrofuryl has a good ..." | ||
| Vol 15 (2023): (Suppl. 1) | Prolonged observation after the use of cladribine in multiple sclerosis: efficacy and safety | Abstract similar documents |
| A. D. Kukushkina, A. N. Boyko | ||
| "... are a selective, highly effective oral form of IRT for MS patients with exacerbations that targets lymphocytes ..." | ||
| Vol 15, No 6 (2023) | Admitting a patient with musculoskeletal pain following COVID-19 disease | Abstract similar documents |
| I. D. Romanov, O. A. Shavlovskaya, I. A. Bokova | ||
| "... is effective: stage 1 – injections, stage 2 – oral therapy. ..." | ||
| Vol 15, No 4 (2023) | Pharmaconutraceutical Chondroguard®TRIO – chondroprotector with immunomodulatory activity | Abstract similar documents |
| O. A. Shavlovskaya, Yu. D. Yukhnovskaya, I. D. Romanov, I. A. Bokova | ||
| "... of the intercellular matrix enhance the synthesis of TNFα, IL, and MMP and exacerbate the inflammatory process. Oral ..." | ||
| Vol 15, No 6 (2023) | Choline alfoscerate in the correction of cognitive impairment | Abstract similar documents |
| O. A. Shavlovskaya, I. D. Romanov, I. A. Bokova | ||
| "... in the treatment of CI, it can be concluded that oral administration of CA at a dose of 600 mg/day can ..." | ||
| Vol 13, No 1 (2021) | Role of pathogenetic therapy for diabetic polyneuropathy | Abstract similar documents |
| D. A. Iskra, V. V. Kovalchuk, E. R. Barantsevich | ||
| "... polyneuropathy (DPN). Objective: to compare the efficiency and safety of using oral and injectable α-lipoic acid ..." | ||
| Vol 15, No 2 (2023) | Optimization of migraine attacks relief | Abstract similar documents |
| G. R. Tabeeva, A. V. Amelin, L. R. Akhmadeeva, A. B. Danilov, O. B. Doronina, M. I. Koreshkina, N. V. Latysheva, E. G. Mendelevich, I. V. Sarvilina, A. V. Sergeev, K. V. Skorobogatykh, E. G. Filatova | ||
| "... tablets, oral dispersible forms, injections, nasal sprays, rectal suppositories). Rizatriptan in the form ..." | ||
| Vol 13, No 2 (2021) | Actovegin use in patients with cognitive impairment after coronavirus infection (COVID-19) | Abstract similar documents |
| V. A. Kutashov | ||
| "... Objective: to investigate the effectiveness of long-term oral administration of Actovegin in post ..." | ||
| Vol 12, No 5 (2020) | The quality of prior antithrombotic therapy and the severity of ischemic stroke in atrial fibrillation | Abstract similar documents |
| L. A. Geraskina, M. M. Alieva, A. V. Fonyakin, M. Yu. Maksimova, N. I. Garabova, M. G. Burzhunova | ||
| "... 36 (18%) took antiplatelet agents (APAs). Oral anticoagulants (OACs) were given to 44 patients ..." | ||
| Vol 14, No 1 (2022) | Impact of endothelial inflammation on depression in patients with cerebral microangiopathy: a prospective study | Abstract similar documents |
| O. V. Vorobyeva, A. A. Pilipovich, V. V. Fateeva | ||
| "... with CM. All patients had correction of hypotensive, antiplatelet, anticoagulant, lipid-lowering ..." | ||
| Vol 12, No 2 (2020) | Efficacy and safety of different nonsteroidal anti-inflammatory drugs for acute neck and back pain | Abstract similar documents |
| E. Yu. Plotnikova, V. N. Zolotukhina, L. K. Isakov, M. N. Sinkova, M. A. Sinkov | ||
| "... patients (4 groups, each having 30 people) with acute dorsalgia who took different oral NSAIDs for 7 days ..." | ||
| 1 - 70 of 104 Items | 1 2 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
